Tenormin: Expert Cardiovascular Control for Hypertension & Angina
| Product dosage: 100mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $3.87 | $38.70 (0%) | 🛒 Add to cart |
| 20 | $2.15 | $77.40 $43.00 (44%) | 🛒 Add to cart |
| 30 | $1.86 | $116.10 $55.90 (52%) | 🛒 Add to cart |
| 60 | $0.86 | $232.20 $51.60 (78%) | 🛒 Add to cart |
| 90 | $0.72 | $348.30 $64.50 (81%) | 🛒 Add to cart |
| 120 | $0.65 | $464.40 $77.40 (83%) | 🛒 Add to cart |
| 180 | $0.57 | $696.60 $103.20 (85%) | 🛒 Add to cart |
| 270 | $0.51 | $1044.90 $137.60 (87%) | 🛒 Add to cart |
| 360 | $0.47
Best per pill | $1393.20 $167.70 (88%) | 🛒 Add to cart |
Tenormin (atenolol) is a cardioselective beta-blocker prescribed for the management of hypertension (high blood pressure) and angina pectoris (chest pain). As a cornerstone of cardiovascular therapy, it works by blocking the effects of adrenaline on the heart and blood vessels, effectively reducing heart rate, cardiac output, and blood pressure. This action decreases the myocardial oxygen demand, making it a vital agent in the long-term management of chronic cardiovascular conditions under strict medical supervision.
Features
- Active Pharmaceutical Ingredient: Atenolol 25mg, 50mg, or 100mg tablets.
- Pharmacological Class: Cardioselective (β1-selective) adrenergic receptor blocker.
- Bioavailability: Approximately 50% of an oral dose is absorbed.
- Half-life: Elimination half-life is 6-7 hours, supporting a twice-daily or once-daily dosing regimen.
- Excretion: Primarily renal; dosage adjustment is required in patients with impaired renal function.
- Presentation: Film-coated, scored tablets for accurate dose splitting.
Benefits
- Provides consistent 24-hour blood pressure control, reducing the long-term risk of stroke, myocardial infarction, and kidney damage.
- Effectively reduces the frequency and severity of angina attacks, improving exercise tolerance and quality of life.
- Cardioselective action primarily targets β1-receptors in the heart, offering a favorable side effect profile compared to non-selective beta-blockers at therapeutic doses.
- Helps manage heart rate in certain arrhythmias, contributing to overall cardiac stability.
- Proven efficacy and safety profile established through decades of widespread clinical use and evidence-based research.
Common use
Tenormin is indicated for the management of essential hypertension, either as monotherapy or in combination with other antihypertensive agents like thiazide diuretics. It is also indicated for the long-term management of chronic stable angina pectoris. In some cases, it may be used as part of a management strategy following a myocardial infarction (heart attack) and for the control of heart rate in certain cardiac arrhythmias, such as sinus tachycardia or atrial fibrillation. Its use is always predicated on a comprehensive cardiovascular assessment by a qualified physician.
Dosage and direction
Dosage is highly individualized and must be determined by a physician based on the patient’s clinical condition and response. For hypertension, the usual initial dose is 50 mg administered once daily, which may be increased to 100 mg once daily after one to two weeks. A maximum daily dose of 100 mg is typically recommended. For angina pectoris, the usual initial dose is 50 mg once daily, which can be increased to 100 mg once daily or 50 mg twice daily based on clinical response. The dosage must be reduced in patients with renal impairment. It is crucial to follow the prescribed schedule exactly. Abrupt discontinuation of Tenormin can precipitate severe angina or myocardial infarction and must be avoided; dosage should be tapered gradually under medical guidance.
Precautions
Patients should inform their doctor of any history of asthma, bronchitis, emphysema, diabetes, liver disease, kidney disease, or overactive thyroid (hyperthyroidism). Tenormin can mask the fast heart rate typically associated with hypoglycemia (low blood sugar), which is a critical consideration for diabetic patients. It may also mask signs of hyperthyroidism. Caution is advised when performing tasks requiring alertness, such as driving, as it may cause dizziness or fatigue, especially when initiating therapy. Patients should be monitored for signs of worsening heart failure. Regular monitoring of heart rate, blood pressure, and, where applicable, blood glucose is essential during therapy.
Contraindications
Tenormin is contraindicated in patients with known hypersensitivity to atenolol or any component of the formulation. Its use is prohibited in patients with:
- Sinus bradycardia (heart rate less than 45-50 beats per minute)
- Second- or third-degree heart block (without a permanent pacemaker)
- Cardiogenic shock
- Overt cardiac failure
- Sick sinus syndrome
- Severe peripheral arterial circulatory disorders
Possible side effect
Like all medicines, Tenormin can cause side effects, although not everybody gets them. Common side effects include cold extremities (hands and feet), fatigue, dizziness, and bradycardia (slow heart rate). Less frequently, patients may experience shortness of breath (especially in patients with a history of bronchospasm), depression, sleep disturbances, and gastrointestinal upset (nausea, diarrhea). While rare, serious side effects require immediate medical attention and include signs of heart failure (e.g., worsening shortness of breath, swelling of ankles/feet), unusually slow heart rate, severe dizziness/fainting, or mood changes. This is not a complete list of possible side effects.
Drug interaction
Concurrent use of Tenormin with other drugs requires careful physician oversight due to potential interactions. Significant interactions include:
- Other antihypertensives (e.g., calcium channel blockers like verapamil or diltiazem): Potentiates the blood pressure-lowering and heart rate-slowing effects, increasing the risk of bradycardia and hypotension.
- Insulin and oral hypoglycemics: May enhance the hypoglycemic effect and mask tachycardia (a key warning sign of hypoglycemia).
- Digoxin: Concurrent use increases the risk of bradycardia.
- Clonidine: Abrupt withdrawal of clonidine during therapy with beta-blockers can exacerbate rebound hypertension.
- NSAIDs (e.g., ibuprofen, naproxen): May reduce the antihypertensive effect of Tenormin.
- Patients must provide their doctor with a full list of all prescription, non-prescription, and herbal products they are taking.
Missed dose
If a dose is missed, it should be taken as soon as remembered on the same day. If it is almost time for the next scheduled dose, the missed dose should be skipped, and the regular dosing schedule resumed. A double dose should never be taken to make up for a forgotten one. Maintaining a consistent dosing schedule is critical for stable therapeutic effect.
Overdose
Overdose with Tenormin is a medical emergency characterized by severe bradycardia, hypotension, heart failure, bronchospasm, and hypoglycemia. Signs may also include confusion, loss of consciousness, and seizures. In case of suspected overdose, immediate medical attention must be sought. Treatment is primarily supportive and symptomatic, potentially including the use of atropine (for bradycardia), beta-adrenergic agonists (e.g., isoprenaline, dobutamine), glucagon, and/or cardiac pacing.
Storage
Store Tenormin tablets at room temperature (15°C to 30°C / 59°F to 86°F), in their original container, and protect from light and moisture. Keep all medicines out of the sight and reach of children and pets. Do not use medicine beyond the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting or stopping any medication. Never disregard professional medical advice or delay in seeking it because of something you have read here. The information provided is not exhaustive and may not cover all possible uses, directions, precautions, interactions, or adverse effects.
Reviews
“Tenormin has been a fundamental agent in my cardiology practice for over two decades. Its predictable pharmacokinetics and cardioselectivity make it a reliable choice for initiating beta-blocker therapy in appropriate hypertensive and angina patients, particularly where once-daily dosing supports adherence.” – Cardiologist, 25 years of experience. “In clinical trials and real-world use, atenolol has consistently demonstrated significant efficacy in reducing both systolic and diastolic blood pressure. Its role in secondary prevention post-MI, while now often superseded by other agents, is well-documented in the literature.” – Clinical Pharmacologist. “Patient response is generally positive regarding angina symptom control. The primary challenge in practice is managing the side effect of fatigue and ensuring patients do not discontinue therapy abruptly, which requires thorough patient education.” – General Practitioner.